Just noticed with a couple of media announcements that they are mixing some comments from ODAC directed to Cell Therapeutics (CTIC) with Chemgenex.
CTIC's presentation was an unmitigated disaster. Most of the comments from ODAC highlighted the sloppy nature of their clinical trial and the need to ensure to close the door on trials conducted in this manner.
Also speculation about how long it will take to validate an already available commercial diagnostic test is mute until the meeting with the FDA on 9 April where the requirements will be spelled out.
CXS Price at posting:
44.0¢ Sentiment: None Disclosure: Held